文献速递胃肠外科围术期管理与 ERAS

腹腔镜磁括约肌增强装置用于袖状胃切除术后药物难治性胃食管反流

Laparoscopic magnetic sphincter augmentation device placement for patients with medically-refractory gastroesophageal reflux after sleeve gastrectomy.
PubMed 文献 · Surg Endosc · 2022-04-26

结果显示MSA植入后GERD-HRQL评分从43.8降至16.7(p<0.0001),82%患者停用抗酸药(p<0.0485),77%无术后并发症,无装置移除或腐蚀。MSA是安全可行的替代Roux-en-Y胃旁路术的选项。

要点

  • MSA植入后GERD-HRQL评分显著改善(43.8 vs 16.7,p<0.0001)
  • 82%患者术后停用抗酸药(p<0.0485),77%无术后并发症
  • 无装置移除、腐蚀或装置相关死亡,安全性可接受

核心结论

  • 袖状胃切除术后药物难治性GERD患者植入MSA安全可行,可替代Roux-en-Y胃旁路术且不增加额外风险。
  • MSA植入后反流症状改善,表现为GERD-HRQL评分下降、抗酸药使用减少及患者满意度高。

研究设计与样本

  • 20例女性(91%),2例男性(9%);所有患者术前每日服用抗反流药物控制GERD症状。

主要发现

  • MSA植入前后平均GERD-HRQL评分分别为43.8和16.7,差异显著(p<0.0001)。
  • 77%患者术后无并发症;82%患者术后不再服用任何抗酸药(p<0.0485)。
  • 无患者需要移除MSA装置,无装置腐蚀或装置相关死亡等不良事件。

临床怎么用

  • 对于袖状胃切除术后药物难治性GERD,可考虑MSA装置植入作为Roux-en-Y胃旁路术的替代方案。
  • 需向患者说明MSA可改善反流症状和减少抗酸药使用,但需进一步前瞻性对照研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of the magnetic sphincter augmentation (MSA) in patients with de novo or persistent gastroesophageal reflux disease (GERD) after sleeve gastrectomy has not been thoroughly investigated. OBJECTIVE: The aim of this study is to evaluate the efficacy of MSA device placement in improving GERD symptoms and reducing anti-reflux medication usage in patients with persistent or de novo GERD after sleeve gastrectomy. METHODS: This is a retrospective analysis of patients who underwent laparoscopic MSA device placement between January 2018 and July 2020 after sleeve gastrectomy. RESULTS: A total of twenty-two patients met inclusion criteria. Twenty patients were female (91%) and two patients were male (9%). All patients were taking anti-reflux medications daily to control GERD symptoms prior to MSA device placement. There was a significant improvement in the mean GERD-HRQL survey scores when comparing scores prior to (43.8) and after (16.7) MSA device placement (p < 0.0001). Majority of the patients did well without any post-operative complications (77%). Nearly 82% of patients were no longer taking any anti-acid medications after MSA device placement (p < 0.0485). There were no patients that required MSA device removals. There were no adverse events such as MSA device erosions or device-related mortalities. CONCLUSIONS: MSA device placement in patients with medically refractory GERD after sleeve gastrectomy is a safe and viable alternative to Roux-en-Y gastric bypass without conferring additional risks. We show an improvement in reflux symptoms after MSA device placement as evidenced by decreased post-operative GERD-HRQL scores, decreased anti-acid medication usage, and overall patient satisfaction with the procedure. Further prospective and comparative studies with longer term follow-up are needed to validate the use of MSA in patients who have undergone sleeve gastrectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Patel SH, Smith B, Polak R, et al. Laparoscopic magnetic sphincter augmentation device placement for patients with medically-refractory gastroesophageal reflux after sleeve gastrectomy. Surg Endosc. 2022. PMID: 35474390. doi:10.1007/s00464-022-09261-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。